Atossa Therapeutics Inc (NASDAQ: ATOS) Up 61.36% This Year: What To Expect Next

1d ago, source:

The trading price of Atossa Therapeutics Inc (NASDAQ:ATOS) closed higher on Monday, April 22, closing at $1.42, 3.65% higher ...

Atossa Therapeutics, Inc. (YAG2.SG)

5d ago, source: Yahoo Finance

SEATTLE, April 15, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) and Quantum Leap Healthcare Collaborative™ today announced the initiation ...

Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update

23d ago, source: Business Insider

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on using (Z)-endoxifen ...

Atossa (ATOS) Reports Positive Results From EVANGELINE Study

13d ago, source: Zacks.com on MSN

Atossa Therapeutics, Inc. ATOS recently announced promising safety and efficacy data from the company’s Phase 2 EVANGELINE (Endoxifen Versus exemestANe GosEreLIn) clinical trial. (Z)-endoxifen is ...

Atossa Therapeutics: Strong Buy on Promising EVANGELINE Study Results and Z-endoxifen Efficacy Potential

15d ago, source: Business Insider

Atossa Therapeutics (ATOS) Company Description: Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery ...

Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference

14d ago, source: WDRB

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on using (Z)-endoxifen ...

Atossa Therapeutics, Inc. (ATOS)

5d ago, source: Yahoo Finance

SEATTLE, April 15, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) and Quantum Leap Healthcare Collaborative™ today announced the initiation ...

Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update

23d ago, source: Stockhouse

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on using (Z)-endoxifen to ...

Atossa Therapeutics Inc ATOS

14d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update

23d ago, source: Yahoo Finance

SEATTLE, April 01, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced financial results for the fourth quarter and full year ended December ...